Skip to main content
Glama

Crypto, web, finance and app data tools

Clinical Trials Search

clinical_trials

Search ClinicalTrials.gov by condition, drug/device or sponsor: status, phase, enrollment, start and completion dates, sponsor, interventions and countries. Use for pharma, biotech and patient research.

Tool call template

This tool declares no required parameters. Add optional parameters from the input schema as needed.

{
  "id": 1,
  "jsonrpc": "2.0",
  "method": "tools/call",
  "params": {
    "arguments": {},
    "name": "clinical_trials"
  }
}

Input Schema

NameRequiredDescriptionDefault
limitNo
phaseNo
statusNo
sponsorNo
conditionNo
interventionNo

Output Schema

NameRequiredDescriptionDefault
resultYes

Schema Changelog

Changes observed during successful MCP inspections.

  1. Added

TDQS

B3.3/5.0
Behavior2/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

With no annotations, the description carries the full behavioral burden. It implies a read-only external search and names the upstream source, but says nothing about rate limits, result ordering, pagination, or what happens when all optional filters are omitted — a real risk here since 0 of 6 params are required.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

Two sentences, front-loaded with the searchable dimensions and finished with the intended-audience cue. The enumeration of facets is dense but earns its space; only the filter/output conflation is wasteful.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness2/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

An output schema exists, so return values need not be explained. However, for a six-parameter search tool with zero annotations and zero schema descriptions, the definition leaves too much unsaid: no filter value syntax, no statement that all parameters are optional (and what unfiltered search yields), and no limit/default guidance.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters3/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 0%, so the description must compensate. It does name most filters (condition, sponsor, intervention, status, phase) but omits 'limit' entirely and lists 'enrollment, start and completion dates, countries' that are NOT parameters — blurring filters with returned fields. It also gives no accepted value formats for status/phase, which are clearly controlled vocabularies despite the schema declaring no enums.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

States a specific verb (Search), the exact resource and data source (ClinicalTrials.gov), and the facets it searches on (condition, drug/device, sponsor). None of the siblings (fda_drug_label, fda_recalls, research_papers) cover registry trial search, so it is easily distinguished.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines3/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The closing clause 'Use for pharma, biotech and patient research' gives a domain-level intent, which is better than nothing. But it names no alternative tool and no exclusion conditions, so an agent still has to guess when a regulatory source (e.g. fda_drug_label) is the better pick.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

Resources